Pharmacovigilance: A Roadmap to Early Signal Detection

Growing government and public concern over drug safety has increased the importance of pharmacovigilance activities and highlighted the limitations of relying entirely on traditional methods, such as individual case review. It has therefore become essential for pharmaceutical firms to aggressively detect and manage emerging safety risks to ensure patient safety, minimize costs, and ease regulatory compliance. However early detection is being hindered by a lack of integration across diverse information sources and manual processes. Researchers can no longer that take days or weeks to analyze data. Today's zero tolerance drug safety environment calls for new strategies to quickly identify health safety signals. Click here to learn how new foundational technologies are enabling a more accurate risk/benefit assessment, better analysis of large datasets, and the importance of establishing pharmacovigilance programs to develop a thorough and well-understood safety profile